Navigation Links
Impacts conference on climate change effects
Date:5/24/2013

As the first conference of its kind, Impacts World 2013 from May 27-30th brings together leading scientists and decision makers from politics, business and civil society to discuss a new vision for an integrated climate impact research across sectors and scales.

Webcast of opening press conference of Impacts World 2013 on May 27th, 1pm to 1:55pm and opening plenary from 2pm: http://climate-impacts-2013.org/live

Speakers include:

Connie Hedegaard, EU Commissioner for Climate Action
Joseph Alcamo, UNEP Chief Scientist
Rachel Kyte, Vice President of Sustainable Development, World Bank
John Schellnhuber, Director of PIK

Impacts World 2013 Conference on Climate Change Effects is organized by the Potsdam-Institute for Climate Impact Research (PIK) and the International Institute for Applied Systems Analysis (IIASA).


'/>"/>

Contact: Press Office
press@pik-potsdam.de
49-331-288-2507
Potsdam Institute for Climate Impact Research (PIK)
Source:Eurekalert

Page: 1

Related medicine news :

1. Recent Research Suggests that a “Western-type” Diet Negatively Impacts Ideal Aging, Making Appetite Suppressants Like Prescopodene Essential to Growing Old Gracefully
2. Adult sleepwalking is serious condition that impacts health-related quality of life
3. Latest Book by Rothstein Associates Cautions: Ignoring Emotions in the Workplace is High-Risk Behavior That Impacts the Bottom-Line
4. Excessive alcohol use when youre young could have lasting impacts on your brain
5. Overprescribing of opioids impacts patient safety and public health
6. Study shows large-scale genomic testing feasible, impacts therapy
7. New study examines how ocean energy impacts life in the deep sea
8. Concussions and head impacts may accelerate brain aging
9. Racial make-up of community impacts obesity risk
10. Dartmouth researchers investigate the cognitive effects of athlete head impacts
11. Pediatric epilepsy impacts sleep for the child and parents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... DC (PRWEB) , ... March 30, 2017 , ... ... and organizations submitted a letter to President Trump expressing their support for an ... medical doctors, two Ph.D. scientists and one medical journalist, will hold a press ...
(Date:3/29/2017)... ... March 29, 2017 , ... In the United States alone, up ... year develop other types of metastatic brain tumors(3). Though most meningiomas are benign, metastatic ... focus on finding more effective treatment options, the San Diego Gamma Knife Center ...
(Date:3/29/2017)... ... 2017 , ... Grass pollen is the main cause of hay fever in the United States, ... grass pollen runs from May to July each year; with the worst time for sufferers ... allergen barrier balms ( http://www.haymax.us ) provide an effective defense against grass pollen; they are ...
(Date:3/29/2017)... FL (PRWEB) , ... March 30, 2017 , ... Sublime ... the "Spice of Life" or "Wonder Spice", it has been used for thousands of ... in the East," says Heshelow, author of " Turmeric: How to Use it For ...
(Date:3/29/2017)... ... March 29, 2017 , ... AngioGenesis Labs ... store in Mississippi. AngioGenesis Labs, makers of HeartBoost, BrainBest and BeautyBest, achieved these ... Ingredients in HeartBoost, an over the counter heart healthy drink, can reduce Arterial ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... -- Wound care devices and products are used to ... industry mainly consists of establishments engaged in manufacturing wound ... caused by mechanical, chemical, thermal, and radiogenic trauma; and ... skin related diseases, immunological diseases, and other chronic diseases. ... largest region in the wound care devices market in ...
(Date:3/29/2017)... , March 29, 2017 Global intravenous (IV) iron ... billion by 2021, growing at a CAGR of 5%. ... by a doctor to treat anemia or other iron deficiencies. ... in the body. However, in some cases, oral administrations are ... and intravenous (IV) iron therapy comes into the picture. ...
(Date:3/29/2017)... N.J. , March 29, 2017  Novartis ... Administration (FDA) has accepted the company,s Biologics License ... CTL019 (tisagenlecleucel-T), an investigational chimeric antigen receptor T ... pediatric and young adult patients with B-cell acute ... submission by Novartis for a CAR-T. The priority ...
Breaking Medicine Technology: